Serum CD44 levels preceding the diagnosis of non-Hodgkin's lymphoma

Leukemia and Lymphoma

Volumn 37, Issue 5-6, 2000, Pages 585-592

  Mäenpää, Hanna ^a   Ristamäki, Raija ^c   Virtamo, Jarmo ^b   Franssila, Kaarle ^a   Albanes, Demetrius ^d   Joensuu, Heikki ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Adhesion molecules; Diagnosis; Non Hodgkin's lymphoma; Screening

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; HERMES ANTIGEN; ANTINEOPLASTIC AGENT; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER GRADING; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION; BLOOD; COHORT ANALYSIS; MIDDLE AGED; NEOPLASM; PREDICTION AND FORECASTING; SMOKING; SOLUBILITY; TIME;

AGED; ALPHA-TOCOPHEROL; ANTICARCINOGENIC AGENTS; ANTIGENS, CD44; BETA CAROTENE; CHEMILUMINESCENT MEASUREMENTS; COHORT STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOMA, HIGH-GRADE; LYMPHOMA, LOW-GRADE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS; PREDICTIVE VALUE OF TESTS; SMOKING; SOLUBILITY; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0342657772     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009058511     Document Type: Article

References (29)

1. Jalkanen, S., Bargatze, R.F., de los Toyos J., Butcher E.C. (1987) Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. Journal of Cell Biology, 105, 983-990.
2. Brown, T.A., Bouchard, T., St. John, T., Wayner, E., Carter, W.G. (1991) Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. Journal of Cell Biology, 113, 207-221.
3. Screaton, G.R., Bell, M.V., Jackson, D.G., Cornelis, F.B., Gerth, U., Bell, J.I. (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proceedings of the National Academy of Sciences of the Unated States of America, 89, 1260-1264.
4. Jalkanen, S., Jalkanen, M., Bargatze, R., Tammi, M., Butcher, E.C. (1988) Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. Journal of Immunology, 141, 1615-1623.
5. Jalkanen, S.T., Bargatze, R.F., Herron, L.R., Butcher E.C. (1986) A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. European Journal of Immunology, 16, 1195-1202.
6. Picker, L.J., Nakache, M., Butche, E.C. (1989) Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. Journal of Cell Biology, 109, 927-937.
7. Lesley, J., Hyman, R., Kincade, P.W. (1993) CD44 and its interaction with extracellular matrix. Advances in Immunology, 54, 271-335.
8. Haynes, B.F., Telen, M.J., Hale, L.P., Denning, S.M. (1989) CD44 - a molecule involved in leukocyte adherence and T-cell activation. Immunology Today, 10, 423-428.
9. Miyake, K., Medina, K.L., Hayashi, S., Ono, S., Hamaoka, T., Kincade, P.W. (1990) Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. Journal of Experimental Medicine, 171, 477-488.
10. Koopman, G., van Kooyk, Y., de Graaff, M., Meye, C.J., Frigdor, C.G., Pals S. T. (1990) Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. Journal of Immunology, 145, 3589-3598.
11. Bennett, K.L., Jackson, D.G., Simon, J.C., Tanczos, E., Peach, R., Modrell, B., Stamenkovic, I., Plowman, G., Aruffo, A. (1995) CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. Journal of Cell Biology, 128, 687-698.
12. Gunthert, U., Hoffman, M., Rudy, W., Reber, S., Zoller, M., Haussmann, I., Matzku, S., Wenzel, A., Ponta, H., Herrlich, P. (1991) A new variant of glucoprotein CD44 confers metastatic potiential to rat carcinoma cells. Cell, 65, 13-24.
13. Jalkanen, S., Joensuu, H., Söderström, K-O., Klemi, P. (1991) Lymphocyte homing and clinical behaviour of non-Hodgkin's lymphoma. Journal of Clinical Investigation, 87, 1835-1840.
14. Stauder, R., Eisterer, W., Thaler, J., Gunthert, U. (1995) CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood, 85, 2885-2899.
15. Wielenga, V.J., Heider, K.H., Offerhaus, G.J., Adolf, G.R., van den Berg, F.M., Ponta, H., Herrlich, P., Pals, S.T. (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Research, 53, 4754-4756.
16. Li, H., Hamou, M.F., de Tribolet, N., Jaufeerally, R., Hoffmann, M., Diserens, A.C., Van Meir, E.G. (1993) Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. Cancer Research, 53, 5345-5349.
17. Ristamäki, R., Joensuu H., Salmi, M., Jalkanen, S. (1994) Serum CD44 in malignant lymphoma: An association with treatment response. Blood, 84: 238-243.
18. Ristamäki, R., Joensuu, H., Lappalainen, K., Teerenhovi, L., Jalkanen, S. (1990) Elevated serum CD44 level is associated with unfavorable outcome in non-Hodgkin's lymphoma. Blood, 90, 4039-4041.
19. Guo, Y., Liu, G., Wang, X., Jin, D., Wu, M.C., Ma, J., Sy, M.S. (1994) Potential use of soluble CD44 in serum as an indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Research, 54, 422-426.
20. Harn, H., Ho, L., Shyu, R., Yuan, J., Lin, F., Young, T., Liu, C., Tang, H., Lee, W. (1996) Soluble CD44 isoforms in serum as potiential markers of metastatic gastric carcinoma. Journal of Clinical Gastroenterology, 22, 107-110.
21. Kainz, C., Temfper, C., Winkler, S., Sliutz, G., Koelbl, H., Reinthaller, A. (1995) Serum CD 44 splice variants in cervical cancer patients. Cancer Letters, 90, 231-234.
22. Katoh, S., McCarthy, J., Kincade, P. (1994) Characterization of soluble CD44 in the circulation of mice. Levels are affected by immune activity and tumor growth. Journal of Immunology, 153, 3440-3449.
23. Ristamäki, R., Joensuu, H., Grön-Virta, K., Salmi, M., Jalkanen, S. (1997) Origin and function of circulating CD44 in non-Hodgkin's lymphoma. Journal of Immunology, 158, 3000-3008.
24. The ATBC Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. (1994) New England Journal of Medicine, 330, 1029-1033.
25. Carbone, P., Kaplan, H., Musshoff, K. (1971) Report of the Committee on Hodgkin's disease staging. Cancer Research, 31, 1860-1861.
26. Harris, N.L., Jaffe, E.S., Stein, H. (1994) A revised European-American classification for lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
27. Lennert K. (1992) The Kiel Classification. In Lennert, Felks, A.,C. 11992) Histopathology of Non-Hodgkin's lymphomas. edited by K. Lennert and A.C. Felks, pp. 13-26, New York. Springer.
28. Kittl, E.M., Ruckser, R., Rech Weichselbaum, I., Hinterberger, W., Bauer, K. (1997) Significant elevation of tumor-associated isoforms of soluble CD44 in serum of normal individuals caused by cigarette smoking. European Journal of Clininical Chemistry and Clinical Biochemistry, 35, 81-84.
29. Sy, M.S., Mori, H., Liu, D. (1997) CD44 as a marker in human cancers. Current Opinion in Oncology, 9, 108-110.